The DOI matches its Crossref record; 93 of the 94 references it cites were found in a registry or an index.
Alterations of the microRNA network cause neurodegenerative disease
Abstract
Brain development crucially depends on the integrity of microRNA (miRNA) pathways, which function at the post-transcriptional level as a rheostat of the transcriptome and proteome of the cell. miRNAs are also involved in many other, more specific, aspects of neuronal function such as neurite outgrowth and synapse formation. Complete loss of miRNA expression in the brain leads to neurodegeneration in several animal models. Evidence from patient material is emerging that miRNA dysregulation could, indeed, contribute to neurodegenerative disorders. The translation of proteins previously implicated in familial forms of disease seems to be under control of miRNAs, and changes in miRNAs might explain how these proteins become affected in sporadic neurodegenerative disease. Thus, miRNAs are moving rapidly center stage as key regulators of neuronal development and function in addition to important contributors to neurodegenerative disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In previous study, miR-106b significantly decreased APP levels in HeLa cervical cancer cell line (Hebert et al., 2009).”
From miR-106b impairs cholesterol efflux and increases Aβ levels by repressing ABCA1 expression (2012) · cites this paper as Hebert et al., 2009
In the citing paper
“Interestingly, miR-106b levels were significantly decreased in brains of AD cases and AD mouse model (Hebert et al., 2009; Wang et al., 2011; Wang et al., 2009).”
From miR-106b impairs cholesterol efflux and increases Aβ levels by repressing ABCA1 expression (2012) · cites this paper as Hebert et al., 2009
In the citing paper
“Most interestingly, APP is another miR-106b target gene.”
From miR-106b impairs cholesterol efflux and increases Aβ levels by repressing ABCA1 expression (2012) · cites this paper as Hebert et al., 2009
Citations
Cites
1 retracted
RETRACTED: Human chromosome 21-derived miRNAs are overexpressed in down syndrome brains and hearts
Kuhn, D. E., Nuovo, G. J., Martin, M. M., Malana, G. E., Pleister, A. P., Jiang, J., Schmittgen, T. D., Terry, A. V., Gardiner, K., Head, E., et al. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.03.120 · Cited by 153
RetractedThe C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948
Identification of Novel Genes Coding for Small Expressed RNAs
Lagos-Quintana, M., Rauhut, R., Lendeckel, W., & Tuschl, T. (2001) · Science · doi:10.1126/science.1064921 · Cited by 4,956
MicroRNA genes are transcribed by RNA polymerase II
Lee, Y., Kim, M., Han, J., Yeom, K.-H., Lee, S., Baek, S. H., & Kim, V. N. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600385 · Cited by 4,556
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
John, B., Enright, A. J., Aravin, A., Tuschl, T., Sander, C., & Marks, D. S. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020363 · Cited by 3,796
RAS Is Regulated by the let-7 MicroRNA Family
Johnson, S., Großhans, H., Shingara, J., Byrom, M., JARVIS, R., Cheng, A., Labourier, E., Reinert, K. L., Brown, D., & Slack, F. J. (2005) · Cell · doi:10.1016/j.cell.2005.01.014 · Cited by 3,699
The Microprocessor complex mediates the genesis of microRNAs
Gregory, R. I., Yan, K.-P., Amuthan, G., Chendrimada, T. P., Doratotaj, B., Cooch, N. S., & Shiekhattar, R. (2004) · Nature · doi:10.1038/nature03120 · Cited by 2,851
Flagged first, then by citations
1 of the 94 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 452
Morphine Regulates Dopaminergic Neuron Differentiation via miR-133b
Sánchez-Simón, F. M., Zhang, X. X., Loh, H. H., Law, P., & Rodríguez, R. E. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.066837 · Cited by 109
Barros-Viegas, A. T., Carmona, V., Ferreiro, E. B., Guedes, J. R., Cardoso, A. M., Cunha, P. S., de Almeida, L. P., Oliveira, C. R., Peça, J., Peça, J., et al. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.01.010 · Cited by 112
MicroRNA miR124 is required for the expression of homeostatic synaptic plasticity
Hou, Q., Ruan, H., Gilbert, J. P., Wang, G., Ma, Q., Yao, W., & Man, H. (2015) · Nature Communications · doi:10.1038/ncomms10045 · Cited by 106
Gefen, N., Binder, V., Zaliova, M. K., Linka, Y., Morrow, M., Novosel, A., Edry, L., Hertzberg, L., Shomron, N., Williams, O., et al. (2009) · Leukemia · doi:10.1038/leu.2009.208 · Cited by 106
Yang, L., Han, B., Zhang, Y., Bai, Y., Chao, J., Hu, G., & Yao, H. (2017) · Autophagy · doi:10.1080/15548627.2017.1414755 · Cited by 103
Evans, J. A., Mendonca, P., & Soliman, K. F. A. (2022) · Nutrients · doi:10.3390/nu14112228 · Cited by 111
miR-29c regulates BACE1 protein expression
Zong, Y., Wang, H., Dong, W., Quan, X., Zhu, H., Xu, Y., Huang, L., Ma, C., & Qin, C. (2011) · Brain Research · doi:10.1016/j.brainres.2011.04.035 · Cited by 117
Converging miRNA functions in diverse brain disorders: A case for miR-124 and miR-126
Sonntag, K., Woo, T.-U. W., & Krichevsky, A. M. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.11.035 · Cited by 107
NF-кB-regulated micro RNAs (miRNAs) in primary human brain cells
Lukiw, W. J. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2011.11.022 · Cited by 80
Liu, X., Li, F., Zhao, S., Luo, Y., Kang, J. P., Zhao, H., Yan, F., Li, S., & Ji, X. (2013) · Stroke · doi:10.1161/strokeaha.111.000613 · Cited by 104
Ouyang, Q., Liu, K., Zhu, Q., Deng, H., Le, Y., Ouyang, W., Yan, X., Zhou, W., & Tong, J. (2022) · Small · doi:10.1002/smll.202107534 · Cited by 94
miR-20a regulates expression of the iron exporter ferroportin in lung cancer
Babu, K. R., & Muckenthaler, M. U. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1362-3 · Cited by 101
Up‐regulation of the mitochondrial malate dehydrogenase by oxidative stress is mediated by miR‐743a
Shi, Q., & Gibson, G. E. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07333.x · Cited by 100
Northern blotting analysis of microRNAs, their precursors and RNA interference triggers
Kościańska, E., Staręga‐Rosłan, J., Sznajder, Ł. J., Olejniczak, M., Galka-Marciniak, P., & Krzyżosiak, W. J. (2011) · BMC Molecular Biology · doi:10.1186/1471-2199-12-14 · Cited by 95
Micro RNA let‐7e is associated with the pathogenesis of experimental autoimmune encephalomyelitis
Guan, H., Fan, D., Mrelashvili, D., Hao, H., Singh, N. P., Singh, U. P., Nagarkatti, P. S., & Nagarkatti, M. (2012) · European Journal of Immunology · doi:10.1002/eji.201242702 · Cited by 91
Modification of Cognitive Performance in Schizophrenia by Complexin 2 Gene Polymorphisms
Begemann, M., Grube, S., Papiol, S., Malzahn, D., Krampe, H., Ribbe, K., Friedrichs, H., Radyushkin, K., El-Kordi, A., Benseler, F., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.107 · Cited by 94
MicroRNA-Related Cofilin Abnormality in Alzheimer's Disease
Yao, J., Hennessey, T., Flynt, A. S., Lai, E. C., Beal, M. F., & Lin, M. T. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015546 · Cited by 93
MicroRNA networks surrounding APP and amyloid-β metabolism — Implications for Alzheimer's disease
Schönrock, N., Matamales, M., Ittner, L. M., & Götz, J. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.11.013 · Cited by 96
miRNA dosage control in development and human disease
Cui, Y., Qi, Y., Ding, L., Ding, S., Han, Z., Wang, Y., & Du, P. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.05.009 · Cited by 90
McKiernan, R. C., Jimenez-Mateos, E. M., Sano, T., Bray, I. M., Stallings, R. L., Simon, R. P., & Henshall, D. C. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.06.029 · Cited by 89
Ma, X., Liu, L., & Meng, J. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.09.043 · Cited by 91
RetractedEvidence for a neuroprotective microRNA pathway in amnestic mild cognitive impairment
Weinberg, R. B., Mufson, E. J., & Counts, S. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00430 · Cited by 90
Noorbakhsh, F., Ramachandran, R., Barsby, N. L., Ellestad, K. K., LeBlanc, A. C., Dickie, P., Baker, G. B., Hollenberg, M. D., Cohen, É. A., & Power, C. (2010) · The FASEB Journal · doi:10.1096/fj.09-147819 · Cited by 87
miR‐181a/b downregulation exerts a protective action on mitochondrial disease models
Indrieri, A., Carrella, S., Romano, A., Spaziano, A., Marrocco, E., Fernández‐Vizarra, E., Barbato, S., Pizzo, M., Ezhova, Y., Golia, F. M., et al. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201708734 · Cited by 87
Epigenetic drug discovery for Alzheimer’s disease
Cacabelos, R., & Torrellas, C. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.930124 · Cited by 88
Modes of Aβ toxicity in Alzheimer’s disease
Götz, J., Eckert, A., Matamales, M., Ittner, L. M., & Liu, X. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0750-2 · Cited by 87
MicroRNAs: novel therapeutic targets in neurodegenerative diseases
Roshan, R., Ghosh, T., Scaria, V., & Pillai, B. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.09.009 · Cited by 88
The Outflow Pathway: A Tissue With Morphological and Functional Unity
Saccà, S. C., Gandolfi, S., Bagnis, A., Manni, G., Damonte, G., Traverso, C. E., & Izzotti, A. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25305 · Cited by 83
Augustin, R., Endres, K., Reinhardt, S., Kuhn, P., Lichtenthaler, S. F., Hansen, J., Wurst, W., & Trümbach, D. (2012) · BMC Medical Genetics · doi:10.1186/1471-2350-13-35 · Cited by 82
miR-598 inhibits metastasis in colorectal cancer by suppressing JAG1/Notch2 pathway stimulating EMT
Chen, J., Zhang, H., Chen, Y., Qiao, G., Jiang, W., Ni, P., Liu, X., & Ma, L. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.01.022 · Cited by 81
Roy, B., Lee, E. J., Li, T., & Rampersaud, M. (2022) · Genes · doi:10.3390/genes13030425 · Cited by 83
van Spronsen, M., van Battum, E. Y., Kuijpers, M., Vangoor, V. R., Rietman, M. L., Pothof, J., Gumy, L. F., van IJcken, W. F. J., Akhmanova, A., Pasterkamp, R. J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074907 · Cited by 82
Kynast, K. L., Russe, O. Q., Möser, C. V., Geißlinger, G., & Niederberger, E. (2012) · Pain · doi:10.1016/j.pain.2012.11.010 · Cited by 80
miRNAs as Circulating Biomarkers for Alzheimer's Disease and Parkinson's Disease
Mushtaq, G., H. Greig, N., Anwar, F., A. Zamzami, M., Choudhry, H., M. Shaik, M., A. Tamargo, I., & A. Kamal, M. (2016) · Medicinal Chemistry · doi:10.2174/1573406411666151030112140 · Cited by 78
The Implications of ncRNAs in the Development of Human Diseases
López-Jiménez, E. A., & Andrés‐León, E. (2021) · Non-Coding RNA · doi:10.3390/ncrna7010017 · Cited by 83
Saiyed, A. N., Vasavada, A. R., & Johar, K. (2022) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-022-00413-9 · Cited by 79
Dendritic Spine and Synaptic Plasticity in Alzheimer’s Disease: A Focus on MicroRNA
Reza-Zaldívar, E. E., Hernández-Sapiéns, M. A., Minjarez, B. D., Gómez‐Pinedo, U., Sánchez-González, V., Márquez-Aguirre, A. L., & Canales-Aguirre, A. A. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00255 · Cited by 81
Dhahbi, J. M., Spindler, S. R., Atamna, H., Yamakawa, A., Guerrero, N., Boffelli, D., Mote, P., & Martin, D. I. (2013) · Aging · doi:10.18632/aging.100540 · Cited by 75
Studying micro RNA Function and Dysfunction in Alzheimer’s Disease
Lukiw, W. J., Андреева, Т. В., Grigorenko, A. P., & Rogaev, E. I. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2012.00327 · Cited by 76
Mirnas as Biomarkers of Neurodegenerative Disorders
Viswambharan, V., Thanseem, I., Vasu, M. M., Poovathinal, S. A., & Anitha, A. (2017) · Biomarkers in Medicine · doi:10.2217/bmm-2016-0242 · Cited by 76
Emerging Roles for 3′ UTRs in Neurons
Bae, B., & Miura, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103413 · Cited by 77
Wan, G., Lim, Q. ‘., & Too, H. (2010) · RNA · doi:10.1261/rna.2001610 · Cited by 75
Procyanidins and Alzheimer’s Disease
Zhao, S., Zhang, L., Yang, C., Li, Z., & Rong, S. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1469-6 · Cited by 75
Chen, Q., Huang, X., & Li, R. (2018) · PubMed Central · Cited by 74
Barak, B., Shvarts-Serebro, I., Modai, S., Gilam, A., Okun, E., Michaelson, D. M., Mattson, M. P., Shomron, N., & Ashery, U. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.77 · Cited by 75
Guo, Y., Chen, Y., Carreon, S., & Qiang, M. (2011) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01689.x · Cited by 75
Zhang, Y., Liu, C., Wang, J., Li, Q., Ping, H., Gao, S., & Wang, P. (2016) · Scientific Reports · doi:10.1038/srep24566 · Cited by 73
Renoux, A. J., & Todd, P. K. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.10.006 · Cited by 75
MicroRNAs underlying memory deficits in neurodegenerative disorders
Hernandez-Rapp, J., Rainone, S., & Hébert, S. S. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.04.011 · Cited by 74
Self-citationZhou, H.-J., Wang, L.-Q., Xu, Q.-S., Fan, Z.-X., Zhu, Y., Jiang, H., Zheng, X.-J., Ma, Y.-H., & Zhan, R.-Y. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.09.020 · Cited by 64
Ha, T.-Y. (2011) · Immune Network · doi:10.4110/in.2011.11.5.227 · Cited by 72
Kou, X., Li, J., Liu, X., Chang, J., Zhao, Q., Jia, S., Fan, J., & Chen, N. (2017) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00018.2017 · Cited by 73
Normal Midbrain Dopaminergic Neuron Development and Function in miR-133b Mutant Mice
Heyer, M. P., Pani, A. K., Smeyne, R. J., Kenny, P. J., & Feng, G. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1732-12.2012 · Cited by 71
MicroRNAs as a molecular basis for mental retardation, Alzheimer's and prion diseases
Provost, P. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.069 · Cited by 70
UBE4B, a microRNA-9 target gene, promotes autophagy-mediated Tau degradation
Subramanian, M., Hyeon, S. J., Das, T., Suh, Y. S., Kim, Y. K., Lee, J.-S., Song, E. J., Ryu, H., & Yu, K. (2021) · Nature Communications · doi:10.1038/s41467-021-23597-9 · Cited by 62
MicroRNAs and the Regulation of Tau Metabolism
Hébert, S. S., Sergeant, N., & Buée, L. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/406561 · Cited by 72
Self-citationAberration of miRNAs expression in leukocytes from sporadic amyotrophic lateral sclerosis
Chen, Y., Wei, Q., Chen, X., Li, C., Cao, B., Ou, R., Hadano, S., & Shang, H.-F. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00069 · Cited by 69
Melatonin ameliorates tau-related pathology via the miR-504-3p and CDK5 axis in Alzheimer’s disease
Chen, D., Lan, G., Li, R., Mei, Y., Shui, X., Gu, X., Wang, L., Zhang, T., Gan, C., Xia, Y., et al. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00302-4 · Cited by 68
Liu, H., Dong, J., Duan, Z., Xia, F., Willner, I., & Huang, F. (2024) · Science Advances · doi:10.1126/sciadv.adp6166 · Cited by 68
microRNAs in Neurodegeneration: Current Findings and Potential Impacts
Sharma, S., & Lu, H. (2018) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000420 · Cited by 67
Li, J. J., Dolios, G., Wang, R., & Liao, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090770 · Cited by 65
Geng, L., Zhang, T., Liu, W., & Chen, Y. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.03.037 · Cited by 65
miR-9-5p modulates the progression of Parkinson’s disease by targeting SIRT1
Wang, Z., Sun, L., Jia, K., Wang, X., & Wang, X. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.02.038 · Cited by 66
The potential of microRNAs as biofluid markers of neurodegenerative diseases – a systematic review
Danborg, P. B., Simonsen, A. H., Waldemar, G., & Heegaard, N. H. H. (2014) · Biomarkers · doi:10.3109/1354750x.2014.904001 · Cited by 63
Human Brain Injury and miRNAs: An Experimental Study
Sessa, F., Maglietta, F., Bertozzi, G., Salerno, M., Mizio, G. D., Messina, G., Montana, A., Ricci, P., & Pomara, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071546 · Cited by 63
The Impact of MicroRNAs on Brain Aging and Neurodegeneration
Persengiev, S. P., Kondova, I. I., & Bontrop, R. E. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/359369 · Cited by 61
MicroRNA function and neurotrophin BDNF
Numakawa, T., Richards, M., Adachi, N., Kishi, S., Kunugi, H., & Hashido, K. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.06.009 · Cited by 64
MicroRNAs and Alzheimer′s Disease Mouse Models: Current Insights and Future Research Avenues
Delay, C., & Hébert, S. S. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/894938 · Cited by 63
Self-citationMicroRNA Implications across Neurodevelopment and Neuropathology
Martino, S., di Girolamo, I., Orlacchio, A., Datti, A., & Orlacchio, A. (2009) · BioMed Research International · doi:10.1155/2009/654346 · Cited by 64
Xu, X., Zhuang, C., Wu, Z., Qiu, H., Feng, H., & Wu, J. (2018) · BioMed Research International · doi:10.1155/2018/8181374 · Cited by 61
Decoding the non-coding RNAs in Alzheimer’s disease
Schönrock, N., & Götz, J. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1125-z · Cited by 61
Correcting abnormalities in miR‐124/PTPN1 signaling rescues tau pathology in Alzheimer’s disease
Hou, T., Zhou, Y., Zhu, L., Wang, X., Pang, P., Wang, D., Liuyang, Z., Man, H., Lu, Y., Zhu, L., et al. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.14961 · Cited by 60
Micro RNA association with synucleinopathy conversion in rapid eye movement behavior disorder
Fernández‐Santiago, R., Iranzo, Á., Gaig, C., Serradell, M., Fernández, M., TOLOSA, E. S., Santamaría, J., & Ezquerra, M. (2015) · Annals of Neurology · doi:10.1002/ana.24384 · Cited by 60
Micromanagement of Immune System: Role of miRNAs in Helminthic Infections
Arora, N., Tripathi, S., Singh, A. K., Mondal, P., Mishra, A., & Prasad, A. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00586 · Cited by 60
HOCTAR database: A unique resource for microRNA target prediction
Gennarino, V. A., Sardiello, M., Mutarelli, M., Dharmalingam, G., Maselli, V., Lago, G., & Banfi, S. (2011) · Gene · doi:10.1016/j.gene.2011.03.005 · Cited by 57
Cheng, S., Hou, J., Zhang, C., Xu, C., Wang, L., Zou, X., Yu, H., Shi, Y. S., Yin, Z., & Chen, G. (2015) · Scientific Reports · doi:10.1038/srep10535 · Cited by 59
Wolf, C., & Linden, D. E. J. (2011) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2011.00752.x · Cited by 59
Pathophysiology of translational regulation by microRNAs in multiple sclerosis
Junker, A. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.03.052 · Cited by 56
Deletion of tumor necrosis factor-α ameliorates neurodegeneration in Sandhoff disease mice
Abo-ouf, H., Hooper, A. W. M., White, E. J., van Rensburg, H. J. J., Trigatti, B. L., & Igdoura, S. A. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt250 · Cited by 56
Micro-RNAs and Their Roles in Eye Disorders
Raghunath, A., & Perumal, E. (2015) · Ophthalmic Research · doi:10.1159/000371853 · Cited by 55
Effect of Regulatory Network of Exosomes and microRNAs on Neurodegenerative Diseases
Li, D., Li, Y., Li, Y., Zhu, X., Du, X., Zhou, M., Li, W., & Deng, H. (2018) · Chinese Medical Journal · doi:10.4103/0366-6999.240817 · Cited by 55
High-Resolution Northern Blot for a Reliable Analysis of MicroRNAs and Their Precursors
Kościańska, E., Staręga‐Rosłan, J., Czubala, K., & Krzyżosiak, W. J. (2011) · The Scientific World JOURNAL · doi:10.1100/tsw.2011.11 · Cited by 53
MicroRNAs as new players in the pain game
Niederberger, E., Kynast, K. L., Lötsch, J., & Geißlinger, G. (2011) · Pain · doi:10.1016/j.pain.2011.01.042 · Cited by 53
Specific sequence determinants of miR-15/107 microRNA gene group targets
Nelson, P. T., Wang, W.-X., Mao, G., Wilfred, B. R., Xie, K., Jennings, M. H., Gao, Z., & Wang, X. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr532 · Cited by 53
Systems Approach to Neurodegenerative Disease Biomarker Discovery
Lausted, C. G., Lee, I., Zhou, Y. F., Qin, S., Sung, J., Price, N. D., Hood, L., & Wang, K. (2013) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135928 · Cited by 52
Differential microRNA expression analyses across two brain regions in Alzheimer’s disease
Dobricic, V., Schilling, M., Schulz, J., Zhu, L.-S., Zhou, C.-W., Fuß, J., Franzenburg, S., Zhu, L.-Q., Parkkinen, L., Lill, C. M., et al. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02108-4 · Cited by 48
The Path to microRNA Therapeutics in Psychiatric and Neurodegenerative Disorders
Chan, A. W. S., & Kocerha, J. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00082 · Cited by 54
Batistela, M. S., Josviak, N. D., Sulzbach, C. D., & de Souza, R. L. R. (2016) · International Journal of Neuroscience · doi:10.1080/00207454.2016.1209754 · Cited by 53
Yu, X., Hu, L., Zhang, F., Wang, M., Xia, Z., & Wei, W. (2018) · Microchimica Acta · doi:10.1007/s00604-018-2773-y · Cited by 52
MicroRNA expression changes during zebrafish development induced by perfluorooctane sulfonate
Zhang, L., Li, Y., Zeng, H., Wei, J., Wan, Y., Chen, J., & Xu, S. (2010) · Journal of Applied Toxicology · doi:10.1002/jat.1583 · Cited by 53
Cui, L., Li, Y., Ma, G., Wang, Y., Cai, Y., Liu, S., Chen, Y.-Y., Li, J., Xie, Y., Liu, G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089019 · Cited by 56
MicroRNAs as Potential Circulating Biomarkers for Amyotrophic Lateral Sclerosis
Cloutier, F., Marrero, A., O’Connell, C. M., & Morin, P. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0471-8 · Cited by 52
The emerging roles of MicroRNAs in autism spectrum disorders
Fregeac, J., Colleaux, L., & Nguyen, L. S. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.10.018 · Cited by 52
Wang, Z., Li, D., Tian, X., & Zhang, C. (2021) · Chemical Science · doi:10.1039/d1sc01865e · Cited by 49
Chronological Changes in MicroRNA Expression in the Developing Human Brain
Moreau, M., Bruse, S., Jörnsten, R. J., Liu, Y., & Brzustowicz, L. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060480 · Cited by 48
microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer
Park, S., Kim, J., Eom, K., Oh, S., Kim, S., Kim, G., Ahn, S., Park, K. H., Chung, D., & Lee, H. (2019) · BMC Cancer · doi:10.1186/s12885-019-5620-6 · Cited by 49
Epigenetics: Recent Advances and Its Role in the Treatment of Alzheimer's Disease
Xiao, X., Liu, X., & Jiao, B. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.538301 · Cited by 53
Nasheri, N., Cheng, J. Y., Singaravelu, R., Wu, P., McDermott, M. T., & Pezacki, J. P. (2011) · Analytical Biochemistry · doi:10.1016/j.ab.2011.01.030 · Cited by 50
Kaur, P., Armugam, A., & Jeyaseelan, K. (2012) · Journal of Toxicology · doi:10.1155/2012/870150 · Cited by 48
Advances with microRNAs in Parkinson’s disease research
Yuan, W., Ma, L., Wei, L. L., Wu, F., Hu, Z., & Liu, Z. (2013) · Drug Design Development and Therapy · doi:10.2147/dddt.s48500 · Cited by 51
Metadata
- Authors
- Hébert, S. S., & De Strooper, B.
- Affiliations
- Vlaams Instituut voor Biotechnologie (BE)
- ORCID
- Hébert, Sébastien S.
- Venue
- Trends in Neurosciences
- Publisher
- Elsevier BV
- Published
- 2009-04
- Volume
- 32
- Issue
- 4
- Pages
- 199-206
- ISSN
- 0166-2236 (ISSN-L)
- OpenAlex
- W2041945875
- Cited by
- 452
- References
- 94
- Citations by year
- 2026: 11 · 2025: 9 · 2024: 10 · 2023: 16 · 2022: 18 · 2021: 17 · 2020: 26 · 2019: 26 · 2018: 26 · 2017: 19 · 2016: 37 · 2015: 38 · 2014: 26 · 2013: 39 · 2012: 33
- FWCI
- 2.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Trends in Neurosciences (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Lirias (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- microRNA, neurodegenerative diseases, microRNA dysregulation, post-transcriptional regulation, neuronal development, neurite outgrowth, synaptogenesis, familial neurodegenerative disease
- MeSH terms
- Animals, Humans, Models, Biological, Neurodegenerative Diseases, MicroRNAs, Gene Regulatory Networks
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review